bezafibrate has been researched along with Sleep Wake Disorders in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishida, N; Kudo, T; Oishi, K; Shibata, S; Shirai, H | 1 |
1 other study(ies) available for bezafibrate and Sleep Wake Disorders
Article | Year |
---|---|
PPARalpha is a potential therapeutic target of drugs to treat circadian rhythm sleep disorders.
Topics: Animals; ARNTL Transcription Factors; Basic Helix-Loop-Helix Transcription Factors; Behavior, Animal; Bezafibrate; Blotting, Northern; Cell Cycle Proteins; Circadian Rhythm; DNA-Binding Proteins; Drinking Behavior; Gene Expression Regulation; Hypolipidemic Agents; Liver; Male; Mice; Mice, Inbred ICR; Motor Activity; Nuclear Proteins; Nuclear Receptor Subfamily 1, Group D, Member 1; Period Circadian Proteins; PPAR alpha; Receptors, Cytoplasmic and Nuclear; RNA, Messenger; Sleep Wake Disorders; Time Factors; Transcription Factors | 2007 |